ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,146Medicare Part D Prescriptions Filled, Including Refills

Rank: 96 out of 5176

$1.3M Total Retail Price of All Prescriptions

Rank: 142 out of 5176

733 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 733 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 16,722 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 1,513 1,338 1 2
OMEPRAZOLE 917 755 2 3
LISINOPRIL 737 617 3 5
SIMVASTATIN 585 455 4 1
METFORMIN HCL 521 418 5 7
CRESTOR 488 399 6 15
ATENOLOL-CHLORTHALIDONE 398 366 10 7 161
LOVASTATIN 392 299 8 46
FLUTICASONE PROPIONATE 391 314 9 38
LOSARTAN POTASSIUM 387 314 10 14
ZOLPIDEM TARTRATE 376 349 11 17
PRAVASTATIN SODIUM 362 306 12 23
CARVEDILOL 361 337 13 24
DIOVAN 358 332 14 19
DIOVAN HCT 352 322 15 39
AMMONIUM LACTATE 341 311 16 91
GLIMEPIRIDE 329 246 17 37
LOSARTAN-HYDROCHLOROTHIAZIDE 316 280 18 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 285 199 19 49
HYDROCHLOROTHIAZIDE 261 210 20 10
JANUVIA 237 201 21 25
JANUMET 231 210 22 77
ALENDRONATE SODIUM 228 195 23 18
FUROSEMIDE 218 204 24 8
IBUPROFEN 202 131 25 72
NEXIUM 194 147 26 16
MECLIZINE HCL 190 176 27 81
METOPROLOL TARTRATE 179 136 28 6
ADVAIR DISKUS 173 128 29 32
EXFORGE 173 162 29 126
LEVOTHYROXINE SODIUM 169 144 31 4
PLAVIX 151 138 32 29
GABAPENTIN 149 121 33 21
TAMSULOSIN HCL 145 121 34 20
MIRTAZAPINE 144 142 35 45
POLYETHYLENE GLYCOL 3350 144 128 35 74
AMLODIPINE BESYLATE-BENAZEPRIL 137 107 37 55
BYSTOLIC 136 94 38 96
METOPROLOL SUCCINATE 135 125 39 11
METFORMIN HCL ER 124 106 40 57
GLYBURIDE-METFORMIN HCL 124 114 R 40 76
CLOPIDOGREL 115 102 42 26
VOLTAREN 113 97 43 97
IBANDRONATE SODIUM 112 93 44 211
MICARDIS 110 99 45 154
SPIRIVA 107 103 46 54
LANTUS SOLOSTAR 105 80 47 70
VENTOLIN HFA 104 73 48 64
DONEPEZIL HCL 103 93 49 28
NIFEDIPINE ER 102 86 50 48
ENALAPRIL MALEATE 98 90 51 22
ATENOLOL 97 89 52 12
BETAMETHASONE DIPROPIONATE 97 86 52 260
ATORVASTATIN CALCIUM 96 68 54 9
LOVAZA 95 74 55 43
ACTOS 94 92 56 85
MICARDIS HCT 89 75 57 180
ZETIA 89 50 57 68
PROAIR HFA 87 73 59 60
LEVEMIR FLEXPEN 85 70 60 200
SINGULAIR 76 64 61 62
ISOSORBIDE MONONITRATE ER 74 73 62 44
AVODART 73 73 63 107
LACLOTION 69 49 64 299
DICLOFENAC SODIUM 69 63 64 160
CLONIDINE HCL 68 59 66 79
SERTRALINE HCL 67 53 67 30
RAMIPRIL 65 55 68 50
NAMENDA 65 53 68 47
FAMOTIDINE 64 54 70 58
NAPROXEN 64 36 70 95
LANTUS 63 51 72 66
SINGLE USE SWAB 63 42 72 108
LABETALOL HCL 62 24 74 114
ECONAZOLE NITRATE 60 46 75 340
MELOXICAM 59 54 76 53
EVISTA 55 45 77 65
RANITIDINE HCL 55 46 77 36
COREG CR 54 54 79 275
COMBIVENT 52 49 80 156
PRANDIN 52 48 80 150
TRAMADOL HCL-ACETAMINOPHEN 52 42 80 116
BENAZEPRIL HCL 52 43 80 131
TRAMADOL HCL 51 42 84 40
DILTIAZEM 24HR ER 50 26 85 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.